Tender detail
Open-house pharmaceutical rebate agreements for medicines containing dienogest and estrogen, ATC G03FA15
Summary
The procurement concerns non-exclusive pharmaceutical rebate agreements for medicines containing the active ingredients dienogest and estrogen (ATC G03FA15). Agreements may be concluded at any time during the period from 1 December 2026 to 30 November 2028. Medicines included on the BfArM list of children’s medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.